Fetoplacental mosaicism: Potential implications for false-positive and false-negative noninvasive prenatal screening results

Genetics in Medicine

Volumn 16, Issue 8, 2014, Pages 620-624

  Grati, Francesca R ^a   Malvestiti, Francesca ^a   Ferreira, Jose C P B ^b   Bajaj, Komal ^b   Gaetani, Elisa ^a   Agrati, Cristina ^a   Grimi, Beatrice ^a   Dulcetti, Francesca ^a   Ruggeri, Anna M ^a   De Toffol, Simona ^a   Maggi, Federico ^a   Wapner, Ronald ^c   Gross, Susan ^b   Simoni, Giuseppe ^a  

^a TOMA Advanced Biomedical Assays SpA   (Italy)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

cell free placental DNA; false negative rate; false positive rate; fetoplacental mosaicism; noninvasive prenatal screening

Indexed keywords

AMNIOCENTESIS; AMNION FLUID; AMNION FLUID ANALYSIS; ARTICLE; CHORION VILLUS; CHORION VILLUS SAMPLING; CHROMOSOME ANALYSIS; CYTOTROPHOBLAST; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FETOPLACENTAL MOSAICISM; FETUS; FETUS DISEASE; HUMAN; HUMAN TISSUE; KARYOTYPING; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MESENCHYME; METAPHASE; MONOSOMY X; MOSAICISM; NON INVASIVE MEASUREMENT; PLACENTA DISORDER; PRENATAL SCREENING; RETROSPECTIVE STUDY; TRISOMY 13; TRISOMY 18; TRISOMY 21; CYTOLOGY; EMBRYOLOGY; KARYOTYPE; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; TRISOMY; TROPHOBLAST;

DNA;

CHORIONIC VILLI SAMPLING; DNA; FEMALE; HUMANS; KARYOTYPE; KARYOTYPING; MOSAICISM; PREGNANCY; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; TRISOMY; TROPHOBLASTS;

EID: 84905571246     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2014.3     Document Type: Article

References (28)

1. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7
2. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP; MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901
3. Chiu RW, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validity study. BMJ 2011;342:c7401
4. Verweij EJ, Jacobsson B, Van Scheltema PA, et al. European Non-Invasive Trisomy Evaluation (EU-NITE) study: A multicenter prospective cohort study for noninvasive fetal trisomy 21 testing. Prenat Diagn 2013;22:1-6
5. Samuel A, Bonanno C, Oliphant A, Batey A, Wright JD. Fraction of cell-free fetal DNA in the maternal serum as a predictor of abnormal placental invasion-A pilot study. Prenat Diagn 2013;33:1-4
6. Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 2006;169:400-4
7. Flori E, Doray B, Gautier E, et al. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto-And syncytio-Trophoblastic cells. Case report. Hum Reprod 2004;19:723-4
8. Faas BH, De Ligt J, Janssen I, et al. Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells. Expert Opin Biol Ther 2012;12 Suppl 1:S19-26
9. Morain S, Greene MF, Mello MM. A new era in noninvasive prenatal testing. N Engl J Med 2013;369:499-501
10. Mennuti MT, Cherry AM, Morrissette JJ, Dugoff L. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?. Am J Obstet Gynecol 2013;209:415-9
11. Mozersky J, Mennuti MT. Cell-free fetal DNA testing: Who is driving implementation?. Genet Med 2013;15:433-4
12. Gao Y, Stejskal D, Jiang F, Wang W. A T18 false negative result by NIPT in a XXX, T18 case due to placental mosaicism. Ultrasound Obstet Gynecol 2013. doi:10.1002/uog.13240
13. Pan M, Li FT, Li Y, et al. Discordant results between fetal karyotyping and noninvasive prenatal testing by maternal plasma sequencing in a case of uniparental disomy 21 due to trisomic rescue. Prenat Diagn 2013;33:598-601
14. Grati FR, Grimi B, Frascoli G, et al. Confirmation of mosaicism and uniparental disomy in amniocytes, after detection of mosaic chromosome abnormalities in chorionic villi. Eur J Hum Genet 2006;14:282-8
15. Grati FR, Malvestiti F, Grimi B, et al. QF-PCR as a substitute for karyotyping of cytotrophoblast for the analysis of chorionic villi: Advantages and limitations from a cytogenetic retrospective audit of 44,727 first-Trimester prenatal diagnoses. Prenat Diagn 2013;33:502-8
16. Simoni G, Brambati B, Danesino C, et al. Efficient direct chromosome analyses and enzyme determinations from chorionic villi samples in the first trimester of pregnancy. Hum Genet 1983;63:349-57
17. Verma RS, Babu A. Human Chromosomes Principles and Techniques. McGraw-Hill, Inc, 1995:24-6 (protocol 2.16
18. McKinlay Gardner RJ, Sutherland GR, Shaffer LG: Chromosome Abnormalities and Genetic Counseling (Oxford Monographs on Medical Genetics), 4th edn, chapter 27. Oxford University Press: New York, 2012:439-85
19. Tough calls on prenatal tests. The Wall Street Journal. http://online.wsj.com/article/SB10001424127887324883604578398791568615644. Accessed 23 August 2013
20. Hui L, Bianchi DW. Cell-free fetal nucleic acids in amniotic fluid. Hum Reprod Update 2011;17:362-71
21. Bennington JL. The development and tructure of the placenta. In: Pathology of the Placenta (Major Problems in Pathology), vol. 8. Sauders: London, 1978: 1-37
22. Ciblis LA. Growth of the placenta villi in the first trimester. J Reprod Med 1968;1:377-387
23. Kaufmann P. Development and differentiation of the human placental villous tree. Bibl Anat 1982;22:29-39
24. Futch T, Spinosa J, Bhatt S, De Feo E, Rava RP, Sehnert AJ. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013;33:569-74
25. Yao H, Zhang L, Zhang H, et al. Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X. Prenat Diagn 2012;32: 1114-6
26. Osborne CM, Hardisty E, Devers P, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 2013;33:609-11
27. Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn 2013;33:667-74
28. Benn P, Cuckle H, Pergament E. Non-invasive prenatal testing for aneuploidy: Current status and future prospects. Ultrasound Obstet Gynecol 2013;42: 15-33